UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
American journal of obstetrics and gynecology, ISSN 0002-9378, 09/2017, Volume 217, Issue 3, pp. 282 - 302
soluble vascular endothelial growth factor receptor-1 (sVEGFR-1) | large for gestational age (LGA) | soluble endoglin (sEng) | mitochondria | nutritional sensing | mTOR | placental growth factor (PlGF) | fms-like tyrosine kinase-1 (sFlt-1) | insulin resistance | macrosomia | obesity | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Hypoglycemic Agents - therapeutic use | Maternal Nutritional Physiological Phenomena | Metformin - therapeutic use | TOR Serine-Threonine Kinases - metabolism | Maternal-Fetal Exchange | Humans | Metformin - pharmacology | Fetal Development | Neoplasms - prevention & control | Longevity | Hypoglycemic Agents - pharmacology | Randomized Controlled Trials as Topic | Pregnancy | Pre-Eclampsia - prevention & control | Female | Diabetes, Gestational - drug therapy | Prevention | Medical research | Endothelial growth factors | Pregnant women | Preeclampsia | Medicine, Experimental | Diabetes in pregnancy | Metformin | Prediabetic state | Cancer | Insulin resistance | Index Medicus | Abridged Index Medicus
Journal Article
European journal of pharmacology, ISSN 0014-2999, 04/2014, Volume 728, Issue 1, pp. 135 - 140
Type 2 diabetes | Atorvastatin | Insulin resistance | Hypertriglyceridemia | Impaired glucose tolerance | Glucose area under the curve | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Glucose Tolerance Test | Blood Glucose - analysis | Rats, Wistar | Cholesterol - blood | Heptanoic Acids - therapeutic use | Diabetes Mellitus, Type 2 - prevention & control | Insulin Resistance | Body Weight - drug effects | Rats | Male | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Atorvastatin Calcium | Animals | Diabetes Mellitus, Experimental - prevention & control | Pyrroles - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipid Metabolism - drug effects | Triglycerides - blood | Heptanoic Acids - administration & dosage | Diabetes Mellitus, Experimental - metabolism | Pyrroles - therapeutic use | Prevention | Glucose metabolism | Streptozocin | Analysis | Body weight | Physiological aspects | Glucose | Dextrose | Antilipemic agents | Index Medicus
Journal Article
Nature medicine, ISSN 1078-8956, 08/2009, Volume 15, Issue 8, pp. 940 - 945
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Diabetes Mellitus, Experimental - drug therapy | Obesity - drug therapy | Obesity - immunology | Diabetes Mellitus, Type 2 - genetics | Humans | Diabetes Mellitus, Experimental - genetics | Male | Proto-Oncogene Proteins c-kit - metabolism | Cromolyn Sodium - therapeutic use | Obesity - genetics | Organ Specificity - genetics | Diabetes Mellitus, Type 2 - immunology | Mast Cells - metabolism | Female | Obesity - etiology | Proto-Oncogene Proteins c-kit - genetics | Drug Evaluation, Preclinical | Diabetes Mellitus, Type 2 - complications | Obesity - complications | Mice, Transgenic | Mast Cells - drug effects | Diabetes Mellitus, Experimental - immunology | Diet, Atherogenic | Animals | Diabetes Mellitus, Experimental - etiology | Mice | Diabetes Mellitus, Type 2 - drug therapy | Prevention | Obesity | Care and treatment | Physiological aspects | Metabolic diseases | Mast cells | Genetic aspects | Diabetes | Research | Health aspects | Cellular biology | Cytokines | Body fat | Metabolic disorders | Immune system | Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 11/2016, Volume 59, Issue 11, pp. 2298 - 2307
Diabetic retinopathy | Human Physiology | Diabetes complications | Diabetes mellitus, type 2 | Humans | Metabolic Diseases | Internal Medicine | Cardiovascular disease | Diabetic neuropathy | Albuminuria | Follow-up studies | Medicine & Public Health | Diabetic nephropathy | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemic Agents - therapeutic use | Diabetic Neuropathies - prevention & control | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Middle Aged | Albuminuria - therapy | Male | Diabetic Retinopathy - prevention & control | Albuminuria - mortality | Time Factors | Albuminuria - drug therapy | Diabetes Mellitus, Type 2 - mortality | Diabetes Mellitus, Type 2 - therapy | Aged, 80 and over | Adult | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Diabetes Complications - prevention & control | Type 2 diabetes | Care and treatment | Index Medicus
Journal Article
Cardiovascular research, ISSN 0008-6363, 11/2017, Volume 113, Issue 13, pp. 1664 - 1676
Obesity | Arginase | Diabetes | Vascular dysfunction | Fibrosis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Blood Pressure | Vascular Diseases - prevention & control | Ornithine - blood | Obesity - drug therapy | Oxidative Stress | Diabetes Mellitus, Experimental - enzymology | Diabetes Mellitus, Type 2 - genetics | Arginase - metabolism | Diabetes Mellitus, Experimental - genetics | Endothelium, Vascular - drug effects | Male | Endothelium, Vascular - enzymology | Insulin - blood | Obesity - genetics | Vasodilation | Diabetes Mellitus, Experimental - prevention & control | Diet, High-Fat | Metabolic Syndrome - physiopathology | Arginase - antagonists & inhibitors | Dietary Sucrose | Diabetes Mellitus, Experimental - physiopathology | Metabolic Syndrome - enzymology | Genetic Predisposition to Disease | Signal Transduction | Mice, Inbred C57BL | Diabetes Mellitus, Type 2 - enzymology | Diabetes Mellitus, Type 2 - prevention & control | Endothelium, Vascular - physiopathology | Enzyme Inhibitors - pharmacology | Vascular Diseases - genetics | Obesity - physiopathology | Arginase - genetics | Vascular Diseases - physiopathology | Vascular Diseases - enzymology | Mice, Knockout | Phenotype | Animals | Diabetes Mellitus, Type 2 - physiopathology | Metabolic Syndrome - genetics | Arginine - blood | Vascular Stiffness - drug effects | Endothelium, Vascular - pathology | Metabolic Syndrome - prevention & control | Obesity - enzymology | Blood Glucose - metabolism | Nitric Oxide - metabolism | Index Medicus | Original
Journal Article
Diabetes care, ISSN 0149-5992, 01/2012, Volume 35, Issue 1, pp. S11 - S63
United States | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Diabetes Complications - diagnosis | Diabetes Mellitus, Type 2 - therapy | Adult | Female | Diabetes Mellitus - diagnosis | Child | Diabetes Complications - prevention & control | Diabetes Mellitus - diet therapy | Diabetes, Gestational - diagnosis | Hypoglycemic Agents - therapeutic use | Standard of Care | Diabetes Mellitus - drug therapy | Diabetes, Gestational - prevention & control | Evidence-Based Medicine | Pregnancy |